The counties are seeking settlements totaling more than $50 billion for the drugmakers’ marketing practices, which the counties allege downplayed the significant addiction risk posed by opioids.
Teva told the Journal it would defend its practices against the allegations but is prepared to settle the opioid litigation nationally. Johnson & Johnson also said it will defend itself against the claims. Endo and Allergan declined the Journal‘s requests for comment.
The trial’s first phase will determine if the drugmakers are culpable. It will be overseen by Orange County Superior Court Judge Peter Wilson and will last for months, according to the Journal. If Mr. Wilson rules that the drugmakers are liable, the next phase will explore settlement agreements.
More articles on opioids:
Biden releases first-year drug policy plan
Federal judge: Opioid settlements are the smart financial choice for retail pharmacies
Overdose deaths jumped 29% in 2020, CDC says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
